Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

Antibody Therapy Targeting CD47 and CD271 Effectively Suppresses Melanoma Metastasis in Patient-Derived Xenografts.

Ngo M, Han A, Lakatos A, Sahoo D, Hachey SJ, Weiskopf K, Beck AH, Weissman IL, Boiko AD.

Cell Rep. 2016 Aug 9;16(6):1701-1716. doi: 10.1016/j.celrep.2016.07.004. Epub 2016 Jul 28.

2.

Profiling Melanoma Heterogeneity Using Microwell RNA Cytometry.

Dimov IK, Boiko AD.

Methods Mol Biol. 2016 Apr 16. [Epub ahead of print]

PMID:
27083169
3.

Therapeutic implications of melanoma heterogeneity.

Hachey SJ, Boiko AD.

Exp Dermatol. 2016 Jul;25(7):497-500. doi: 10.1111/exd.13002. Epub 2016 May 19.

4.

Isolation of melanoma tumor-initiating cells from surgical tissues.

Boiko AD.

Methods Mol Biol. 2013;961:253-9. doi: 10.1007/978-1-62703-227-8_16.

5.

VHL loss in renal cell carcinoma leads to up-regulation of CUB domain-containing protein 1 to stimulate PKC{delta}-driven migration.

Razorenova OV, Finger EC, Colavitti R, Chernikova SB, Boiko AD, Chan CK, Krieg A, Bedogni B, LaGory E, Weissman IL, Broome-Powell M, Giaccia AJ.

Proc Natl Acad Sci U S A. 2011 Feb 1;108(5):1931-6. doi: 10.1073/pnas.1011777108. Epub 2011 Jan 13.

6.

Human melanoma-initiating cells express neural crest nerve growth factor receptor CD271.

Boiko AD, Razorenova OV, van de Rijn M, Swetter SM, Johnson DL, Ly DP, Butler PD, Yang GP, Joshua B, Kaplan MJ, Longaker MT, Weissman IL.

Nature. 2010 Jul 1;466(7302):133-7. doi: 10.1038/nature09161. Erratum in: Nature. 2011 Feb 17;470(7334):424.

7.

A systematic search for downstream mediators of tumor suppressor function of p53 reveals a major role of BTG2 in suppression of Ras-induced transformation.

Boiko AD, Porteous S, Razorenova OV, Krivokrysenko VI, Williams BR, Gudkov AV.

Genes Dev. 2006 Jan 15;20(2):236-52.

8.

Secreted transforming growth factor beta2 activates NF-kappaB, blocks apoptosis, and is essential for the survival of some tumor cells.

Lu T, Burdelya LG, Swiatkowski SM, Boiko AD, Howe PH, Stark GR, Gudkov AV.

Proc Natl Acad Sci U S A. 2004 May 4;101(18):7112-7. Epub 2004 Apr 26.

9.

Cdk4 disruption renders primary mouse cells resistant to oncogenic transformation, leading to Arf/p53-independent senescence.

Zou X, Ray D, Aziyu A, Christov K, Boiko AD, Gudkov AV, Kiyokawa H.

Genes Dev. 2002 Nov 15;16(22):2923-34.

10.

Supplemental Content

Loading ...
Support Center